While ABC triblock copolymers are known to form a plethora of dual-mode (i.e., order-on-order) nanostructures, bicomponent ABA triblock copolymers normally self-assemble into single morphologies at thermodynamic incompatibility levels up to the strong-segregation regime. In this study, we employ on-lattice Monte Carlo simulations to examine the phase behavior of molecularly asymmetric A(1)BA(2) copolymers possessing chemically identical endblocks differing significantly in length. In the limit of superstrong segregation, interstitial micelles composed of the minority A(2) endblock are observed to arrange into two-dimensional hexagonal arrays along the midplane of B-rich lamellae in compositionally symmetric (50:50 A:B) copolymers. Simulations performed here establish the coupled molecular-asymmetry and incompatibility conditions under which such micelles form, as well as the temperature dependence of their aggregation number. Beyond an optimal length of the A(2) endblock, the propensity for interstitial micelles to develop decreases, and the likelihood for colocation of both endblocks in the A(1)-rich lamellae increases. Interestingly, the strong-segregation theory of Semenov developed to explain the formation of free micelles by diblock copolymers accurately predicts the onset of interstitial micelles confined at nanoscale dimensions between parallel lamellae.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1103/PhysRevE.91.010601 | DOI Listing |
Nanoscale
October 2024
Science Department, University of Roma Tre, Via della Vasca Navale 84, 00146, Rome, Italy.
Nanometer-sized clusters are often targeted due to their potential applications as nanoreactors or storage/delivery devices. One route to assemble and stabilize finite structures consists of imparting directional bonding patterns between the nanoparticles. When only a portion of the particle surface is able to form an inter-particle bond, finite-size aggregates such as micelles and vesicles may form.
View Article and Find Full Text PDFNanoscale
September 2024
Department of Chemistry, UGC Centre for Advanced Studies-II, Guru Nanak Dev University, Amritsar, Punjab 143005, India.
We report a facile synthesis of cetyltrimethylammonium bromide (CTAB) templated AuAg alloy@AgBr Janus-nanoparticles (JNPs) using a non-conventional top-down approach with precise control over symmetry breaking. The addition of AgNO to a micellar solution of CTAB results in micelle-stabilized AgBr colloids having excess Ag at the interstitial sites of AgBr. AgBr colloids undergo weak self-assembly supported by inter-micellar interactions.
View Article and Find Full Text PDFInt J Pharm
June 2024
College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China. Electronic address:
Most nanomedicines with suitable sizes (normally 100-200 nm) exhibit favorable accumulation in the periphery of tumors but hardly penetrate into deep tumors. Effective penetration of nanomedicines requires smaller sizes (less than 30 nm) to overcome the elevated tumor interstitial fluid pressure. Moreover, integrating an efficient diagnostic agent in the nanomedicines is in high demand for precision theranostics of tumors.
View Article and Find Full Text PDFAAPS PharmSciTech
April 2024
Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai, 400056, Maharashtra, India.
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease that has been well-reported in the medical literature. Its incidence has risen, particularly in light of the recent COVID-19 pandemic. Conventionally, IPF is treated with antifibrotic drugs-pirfenidone and nintedanib-along with other drugs for symptomatic treatments, including corticosteroids, immunosuppressants, and bronchodilators based on individual requirements.
View Article and Find Full Text PDFBioengineering (Basel)
June 2023
College of Pharmacy, Jinan University, Guangzhou 511436, China.
Idiopathic pulmonary fibrosis (IPF) refers to chronic progressive fibrotic interstitial pneumonia. It is called a "tumor-like disease" and cannot be cured using existing clinical drugs. Therefore, new treatment options are urgently needed.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!